Wall Street Breakfast cover image

Futures slip amid renewed tariff-related uncertainty

Wall Street Breakfast

00:00

Novo Nordisk trial setback details

Julie Morgan explains Novo Nordisk's stock drop after its obesity drug underperformed Eli Lilly's tirzepatide in phase three.

Play episode from 04:45
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app